New generic valsartan approved to address shortages
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers...
List view / Grid view
News
European firms fuel growth in patent applications
Pharmaceutical and biotechnology patent applications increased by 13 percent last year, with over 6,000 applications coming from European companies...
Project launched to tackle lab inefficiency, support AI adoption
A project backed by major pharma will advance the Lab of the Future with proof of concept software to digitise experiment methods…
Forum LABO PARIS reveals the nominees in the 2019 Innovation Awards
Forum LABO PARIS has revealed the nominees in the 2019 Innovation Awards, which reward the exhibitors’ know-how and the most outstanding new products...
Watson-Marlow expert Dr. Sade Mokuolu to present Biomanufacturing Masterclass at INTERPHEX 2019
Watson-Marlow Fluid Technology Group has partnered with Interphex to promote safer, more reliable bioprocessing....
Continuous manufacturing method used to make generic lomustine
The goal is to improve manufacturing flexibility, enhance quality and uniformity, while lowering the costs for patients...
Industry experts combine to create safer intravenous delivery
The Italian Biochemical Institute, Comecer, and Particle Measuring Systems share expertise to develop and manufacture a safer intravenous solution...
Indian government plans to colour code generics
Colour-coded generics might help consumers differentiate between generics and branded medicines...
Statins might be linked to increased risk of diabetes
Researchers have identified a possible association between use of statins and developing type 2 diabetes after following patients for 15 years...
FDA commissioner Scott Gottlieb resigns
Scott Gottlieb has announced that he will resign from the position of commissioner of the US Food and Drug Administration (FDA) at the end of the month...
Adjusted fees for EMA applicants from April 1st
The EMA has announced that fees for new drug applications will be different from the beginning of April 2019, taking into account the rate of inflation...
Lilly introduces cheaper generic insulin in the US
The generic version will cost 50 percent less that the current Humalog list price...
Pharma drug delivery market worth $1,694.7 billion by 2023
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
FDA finds another carcinogenic impurity in ARB blood pressure drug
FDA is 'deeply concerned' about a third type of nitrosamine impurity detected in angiotensin II receptor blocker (ARB) medicines...
Six new licensing deals for drug and gene therapy development firm
Oxford Genetics has won six new licensing deals for its scalable drug and gene therapy manufacturing in the synthetic biology sector...
